Yuhan Corporation 000100
KRX · South Korea · Health Technology
KRW 74,800.00+2,000.00 (+2.75%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
CJ Biomaterials, Yuhan-Kimberly Nonwoven Paper Towel CJ Biomaterials and Yuhan-Kimberly launched the world’s first reusable nonwoven paper towel made with PHACT™ PHA under the Kleenex® brand that will not create persistent microplastics. The Kleenex® Biodegradable Reusable Dishtowel is the first product developed through CJ Biomaterials – Yuhan-Kimberly 2022 partnershipNew 100% biobased towel is a combination of cellulose and amorphous PHA and will not produce persistent microplastics WOBURN, Ma
Key opportunities in the prostate cancer market include innovation in androgen receptor degraders, radiopharmaceuticals, and immune-targeted therapies. Strategic collaborations and acquisitions suggest growth in personalized and precise treatment options, enhancing therapeutic efficacy and patient outcomes globally.Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Prostate Cancer - Competitive Landscape, 2026" report has been added to ResearchAndMarkets.com's offering.This "Prostate Cancer - Compe
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.